Publication | Open Access

Liquid chromatography–tandem mass spectrometric assay for the quantification of CDK4/6 inhibitors in human plasma in a clinical context of drug-drug interaction

Therapeutic Drug MonitoringPharmacokinetic ModelingMedicineBioanalysisMass SpectrometryHuman PlasmaAnalytical ChemistryCdk4/6 InhibitorsClinical ChemistryPharmacodynamic ModelingChromatographyPharmacologyRadiation OncologyPharmacokineticsDrug-drug InteractionDrug DiscoveryDrug Analysis